Expert Speaker Faculty

Take a look at the star-studded speaker faculty for the 8th Targeted Radiopharmaceuticals Summit

Guido Würth

Head of Corporate Development & Radiopharma Medical & Health; Sales; Operations
Affibody AB

Fredrik Frejd

Chief Scientific Officer
Affibody AB

Mark Dornan

Chief Executive Officer
Alpha-9 Oncology

Tanja Aarvak

Director, Program Management, Alpha Radioligand Therapy
ARTBIO

Mark Fielding

Director - Chemistry, Manufacturing, Controls, Regulatory Affairs & Radiopharmaceuticals
AstraZeneca

Ming Xu

Vice President - Oncology & Product Team Lead
Bayer

Zahra Trippe

Patient Engagement Lead Oncology
Bayer

Sandra Hennig

Senior RA CMC Strategist
Bayer

Kevin Tabury

Program Pipeline Manager - Head of Innovation & Translational Development Unit
Belgian Nuclear Research Center

Michael Method

Chief Medical Officer
Bicycle Therapeutics

Jitka Riedl

Associate Principal Scientist, Project Leader
Bicycle Therapeutics

Graeme McRobbie

Associate Director Formulation Science Radiopharmaceuticals
Bicycle Therapeutics plc

David Gauden

Chief Executive Officer
Blue Earth Therapeutics Ltd.

Kemp Dolliver

Director of Research
Brookline Capital Markets

Mohamad Haqiqian

PET Radiopharmacy Production & QC Analyst, Radiation Safety Supervisor
Curium Pharma

Christopher Jones

Principal Inspector - Transport Competent Authority
IAEA/Office for Nuclear Regulations

Dan Squair

S&E Manager
Jarlen Capital

Kurt Pike

Senior Director - External Innovation
JNJ

Tomohiko Yamane


Duncan Sutherland


Cara Ferreira

Chief Executive Officer
Lumina Pharmaceuticals

Judson Kimmel

Neuroendocrine Cancer & Theranostics Patient / Advocate
Man Up To Cancer

Kevin Madagan


Gary Inwards

Sr Pharmaceutical Assessor
MHRA

Martin Steegmaier

Chief Scientific Officer
Molecular Partners

Chris Pak

President & Chief Executive Officer
Molecular Targeting Technologies

Waisi Eng

Chief Technology Officer
Norroy North America Inc.

Chaitanya Divgi

Senior Expert - Strategic Therapeutic Innovation
Novartis

Ilya Folitar

Senior Global Program Safety Team Lead and Radiopharmaceutical Safety Lead
Novartis

Ana Filipa Fonseca

Director - Global Radioligand Therapy ,Strategy & Early Portfolio
Novartis AG

Shefali Kakar

VIce President, Global Head PK Sciences - Oncology
Novartis AG

Rich Edwards

Chief Technology Officer
Nuclide Therapeutics

Muhammet Tanc

CEO
Nuclide Therapeutics

Oystein Soug

Chief Executive Officer
Oncoinvent AS

Friedmund Bachmann

Vice President CMC & Project Lead
OncoOne

Frederic Desdouits

Chief Executive Officer
OranoMed

Dirk Pleimes

Group Chief Executive Officer & Chief Marketing Officer
PentixaPharm GmbH

Josie Gayton

Strategic Advisor Theratrop (radiopharm)
Precirix

Guangzhou Han

Chief Scientific Officer
RadAlliance Therapeutics Inc

Vicki Jardine


Dangshe Ma

Sr. Dir
Regeneron

Richard Pearson

CEO
StandardX

Sigal Kalmanson Cusnir

Chief Executive Officer
Starget Pharma

Andreas Furer

Senior Regulatory Manager
Swiss Medic

Marc Robillard

Chief Scientific Officer & Founder
Tagworks Pharmaceuticals BV
Anil Lalwani, Director - Regulatory Chemistry, Manufacturing Controls & MedTech, Telix Pharmaceuticals

Anil Lalwani

Director - Regulatory Chemistry, Manufacturing, Controls & MedTech
Telix Pharmaceuticals

Ajaaz Hussain

Radiopharmaceutical Scientist
The Royal Marsden NHS

Luke Brzozowski

Executive Director - Translational Research & Core Facilities ,Program Sponsor, Theranostics
UHN

Julia Publicover

Director, Translational Research & Innovation
University Health Network

Luigi Aloj

Professor of Nuclear Medicine
University of Cambridge

Haihong Jin

Chief Scientific Officer
Vitsgen Therapeutics, Inc.
Conference Image
Explore the Agenda

Discover the scientific, clinical and commercial strategies that will become your blueprint for accelerating targeted radiopharmaceuticals from discovery to patients.

View Presentations & Speakers
Conference Image
Partner With Us

Showcase your technologies and services to 200+ senior decision-makers actively seeking CROs, CDMOs, isotope suppliers, radiopharmacies, dosimetry providers and specialist partners to advance the next generation of radiopharmaceuticals.

Explore Sponsorship Options
Conference Image
Join Europe's TRP Leaders:

Be part of Europe's most comprehensive targeted radiopharmaceuticals forum, uniting pharma, biotech, regulators, clinical centres, investors and solution providers to shape the future of radioligand therapy.

Register Now